The US market for vascular access devices and accessories was valued at $3bn in 2009 and is projected to reach over $4.6bn by 2016, a new report has found.
The peripherally inserted central catheters (PICCs) and midlines market is expected to see double-digit growth, while the dialysis catheter market will grow steadily due to the introduction of antimicrobial technology, according to iData Research report Markets for Vascular Access Devices and Accessories 2010.
According to the report, the antimicrobial central venous catheter (CVC) market was more than double the value of the conventional CVC market in 2009 and its growth is exceeding that of the conventional market.
a major factor has been the Needlestick Safety and Prevention Act, which has promoted sales of higher-priced safety devices, particularly with the advent of needleless connectors.
A recent move to reduce catheter-related bloodstream infections through changes in Medicare and Medicaid reimbursement has also been a major driver of growth in the overall vascular access market.